ImmunoGen, Inc.
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase…
Biotechnology
US, Waltham [HQ]
IMGN/Financial Reporting
Income Statements
14 Sheets · Starting from 2022In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.00 | 19.00 | 16.00 | 35.00 | 59.00 | 85.00 | 60.00 | 48.00 | 115.00 | 53.00 | 82.00 | 132.00 | 108.00 | 108.00 | |
|
EPS
|
-0.87 | -0.85 | -0.95 | -0.87 | -0.83 | -0.71 | -1.65 | -1.80 | -0.98 | -1.20 | -0.82 | -0.38 | -0.88 | -0.88 | |
| Diluted in mil. | -0.87 | -0.85 | -0.95 | -0.87 | -0.83 | -0.71 | -1.65 | -1.80 | -0.98 | -1.20 | -0.82 | -0.38 | -0.88 | -0.88 | |
|
Profit
|
13.00 | 19.00 | 16.00 | -51.00 | -47.00 | -26.00 | -86.00 | -92.00 | -24.00 | -120.00 | -32.00 | 17.00 | 108.00 | 108.00 | |
| Gross Margin | 100.00 | 100.00 | 100.00 | -145.03 | -78.57 | -30.66 | -144.85 | -190.60 | -21.04 | -223.11 | -39.20 | 13.38 | 99.84 | 99.84 | |
| Pre Tax | -51.00 | -58.00 | -73.00 | -72.00 | -71.00 | -60.00 | -143.00 | -156.00 | -96.00 | -167.00 | -104.00 | -44.00 | -221.00 | -221.00 | |
| Profit Margin | -367.04 | -301.86 | -448.24 | -204.90 | -119.15 | -71.01 | -239.42 | -322.31 | -83.17 | -311.94 | -126.57 | -33.54 | -203.81 | -203.81 | |
| ETR | 0.52 | 3.28 | -0.08 | 0.27 | 0.23 | -10.35 | -13.80 | - - | -38.57 | -4.40 | -17.25 | -50.28 | -0.55 | -0.55 | |
| Net | -50.00 | -58.00 | -73.00 | -72.00 | -71.00 | -60.00 | -143.00 | -156.00 | -96.00 | -167.00 | -122.00 | -66.00 | -222.00 | -222.00 | |
| Profit Margin | -365.14 | -301.86 | -448.24 | -204.90 | -119.15 | -71.01 | -239.42 | -322.31 | -83.17 | -311.94 | -148.40 | -50.40 | -204.93 | -204.93 | |
| EBITDA | -51.00 | -62.00 | -73.00 | -73.00 | -71.00 | -55.00 | -123.00 | -125.00 | -55.00 | -153.00 | -65.00 | -19.00 | -217.00 | -217.00 | |
| EBITDA Margin | -367.88 | -321.69 | -447.48 | -205.46 | -119.43 | -64.65 | -205.87 | -257.46 | -48.16 | -285.15 | -79.89 | -14.88 | -199.98 | -199.98 | |
| Operating Income | -51.00 | -60.00 | -73.00 | -73.00 | -71.00 | -54.00 | -123.00 | -131.00 | -58.00 | -160.00 | -92.00 | -135.00 | -220.00 | -220.00 | |
| Operating Margin | -367.46 | -311.77 | -447.86 | -205.46 | -119.43 | -63.66 | -206.37 | -269.83 | -51.09 | -298.20 | -112.04 | -102.41 | -203.06 | -203.06 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | 20.00 | - - | - - | 4.00 | - - | - - | 4.00 | |
| Loss | -65.00 | -79.00 | -89.00 | -108.00 | -131.00 | -139.00 | -183.00 | -184.00 | -173.00 | -210.00 | -153.00 | -153.00 | -329.00 | -329.00 | |
| Cost of Revenue | - - | - - | - - | -87.00 | -106.00 | -111.00 | -146.00 | -141.00 | -139.00 | -173.00 | -114.00 | -114.00 | - - | - - | |
|
Operating Expenses
|
-65.00 | -79.00 | -89.00 | -108.00 | -131.00 | -139.00 | -183.00 | -43.00 | -173.00 | -210.00 | -153.00 | -153.00 | -329.00 | -329.00 | |
| R&D | -50.00 | -63.00 | -69.00 | -87.00 | -106.00 | -111.00 | -146.00 | -141.00 | -139.00 | -173.00 | -114.00 | -114.00 | -213.00 | -213.00 | |
| G&A | -14.00 | -16.00 | -20.00 | -21.00 | -24.00 | -28.00 | -36.00 | -38.00 | -33.00 | -36.00 | -38.00 | -38.00 | -43.00 | - - | |
| SG&A | -14.00 | -16.00 | -20.00 | -21.00 | -24.00 | -28.00 | -36.00 | -38.00 | -33.00 | -36.00 | -38.00 | -38.00 | -116.00 | -116.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -72.00 | - - | |
| Depreciation and Amortization | -4.00 | -4.00 | -4.00 | -4.00 | -4.00 | -5.00 | -5.00 | -6.00 | -5.00 | -7.00 | -4.00 | -2.00 | -1.00 | -1.00 | |
| Interest Expenses | - - | -1.00 | - - | - - | - - | -5.00 | -20.00 | - - | -16.00 | -10.00 | -16.00 | -23.00 | -4.00 | -4.00 | |
| Other Expenses | - - | -1.00 | - - | - - | - - | - - | - - | -25.00 | -21.00 | - - | -11.00 | -91.00 | - - | -3.00 | |
|
WA Shares Outstanding
|
58.00 | 68.00 | 76.00 | 84.00 | 85.00 | 86.00 | 86.00 | 87.00 | 98.00 | 139.00 | 148.00 | 176.00 | 253.00 | 253.00 | |
| Diluted | 58.00 | 68.00 | 76.00 | 84.00 | 85.00 | 86.00 | 86.00 | 87.00 | 98.00 | 139.00 | 148.00 | 176.00 | 253.00 | 253.00 |